Consistent with these studies, after co-culturing with hHER2-expressing target cancer cells, we identified that a significantly higher proportion of PD-1high hHER2-CAR-T cells than PD-1low CAR-T cells produced IFNγ (Figure 4A). The gene discussed is IFNG; the disease is cancer.